Log In
Print this Print this

GDC-0994, RG7842

  Manage Alerts
Collapse Summary General Information
Company Array BioPharma Inc.
DescriptionSelective inhibitor of extracellular-signal-relgulated kinase (ERK1/2)
Molecular Target MAP kinase (MAPK) (ERK)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerGenentech Inc.;

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today